Humana Inc. (NYSE:HUM) Shares Bought by Austin Asset Management Co Inc

Austin Asset Management Co Inc increased its stake in Humana Inc. (NYSE:HUM) by 7.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,081 shares of the insurance provider’s stock after buying an additional 78 shares during the quarter. Austin Asset Management Co Inc’s holdings in Humana were worth $274,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of HUM. Cidel Asset Management Inc. lifted its position in shares of Humana by 18.4% during the fourth quarter. Cidel Asset Management Inc. now owns 1,870 shares of the insurance provider’s stock worth $474,000 after purchasing an additional 290 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in Humana by 1.7% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 330,906 shares of the insurance provider’s stock worth $83,954,000 after buying an additional 5,497 shares in the last quarter. Choreo LLC boosted its position in Humana by 17.4% in the 4th quarter. Choreo LLC now owns 6,711 shares of the insurance provider’s stock valued at $1,706,000 after buying an additional 995 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Humana by 6.3% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 17,567 shares of the insurance provider’s stock valued at $4,481,000 after acquiring an additional 1,039 shares in the last quarter. Finally, Retirement Systems of Alabama increased its position in shares of Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after acquiring an additional 192,801 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.29% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

HUM has been the subject of a number of analyst reports. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and increased their price target for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Morgan Stanley lifted their price target on shares of Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Wells Fargo & Company reduced their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. TD Cowen boosted their target price on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Finally, KeyCorp started coverage on shares of Humana in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Nineteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, Humana has a consensus rating of “Hold” and an average target price of $297.68.

Humana Stock Performance

HUM opened at $274.06 on Friday. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The stock has a market cap of $33.00 billion, a PE ratio of 24.27, a price-to-earnings-growth ratio of 2.21 and a beta of 0.56. The business’s 50 day moving average is $274.66 and its 200-day moving average is $299.52. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.